Garuda Therapeutics: Funding, Investors & Team (Oct 2026)
The goal of Garuda Therapeutics is to eliminate the need for patient or donor cells in blood stem cell transplantation. Our platform technology for producing readily available, self-renewing blood stem cells is ready to give patients quick, widespread access to reliable, long-lasting, transgene-free blood stem cell treatments. Our approach could offer potentially curative treatments for more than 70 disorders, similar to bone marrow transplants. https://garudatxcom
Garuda Therapeutics has raised $184M across 3 funding rounds on record, the most recent an undisclosed round of $50.0M announced in Mar 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Garuda Therapeutics Company Profile and Key Stats
Latest funding round on record: Mar 2025.
Garuda Therapeutics Funding Rounds
Garuda Therapeutics raised $72.0M in a Series A announced in Sep 2021.
1.4 years later, a Series B of $62.0M was announced in Feb 2023.
2.1 years later, an undisclosed round of $50.0M was announced in Mar 2025.
Garuda Therapeutics Founders and Leadership Team
Contact details for the Garuda Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Garuda Therapeutics Funding Compared to Other Biotechnology Startups
Garuda Therapeutics' latest round of $50.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Garuda Therapeutics in Biotechnology and Cambridge
Companies Similar to Garuda Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Garuda Therapeutics Funding FAQs
What does Garuda Therapeutics do?
The goal of Garuda Therapeutics is to eliminate the need for patient or donor cells in blood stem cell transplantation. Our platform technology for producing readily available, self-renewing blood stem cells is ready to give patients quick, widespread access to reliable, long-lasting, transgene-free blood stem cell treatments. Our approach could offer potentially curative treatments for more than 70 disorders, similar to bone marrow transplants. https://garudatxcom
How much funding has Garuda Therapeutics raised?
Garuda Therapeutics has raised $184M across 3 rounds on record. The most recent is an undisclosed round of $50.0M announced in Mar 2025.
When did Garuda Therapeutics last raise funding?
Garuda Therapeutics' most recent funding round on record is an undisclosed round of $50.0M, announced in Mar 2025.
Who is the CEO of Garuda Therapeutics?
Dhvanit Shah is listed as CEO at Garuda Therapeutics.
Where is Garuda Therapeutics headquartered?
Garuda Therapeutics is based in Cambridge, Massachusetts, United States.
How many employees does Garuda Therapeutics have?
Garuda Therapeutics is in the 11-50 employee band.
How does Garuda Therapeutics' funding compare to other Biotechnology startups?
Garuda Therapeutics' latest round of $50.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Garuda Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Garuda Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.